Sihuan Pharmaceutical Holdings Group (HKG:0460) will conduct a share repurchase worth up to HK$500 million through the open market, according to a Sunday filing.
The buyback will include the HK$5.4 million worth of shares already repurchased by the pharmaceutical company in the first half of the year, the filing said.
The company's stocks were up by 29% in recent trading.
Price (HKD): $0.92, Change: $+0.20, Percent Change: +27.78%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments